[Federal Register Volume 61, Number 111 (Friday, June 7, 1996)]
[Notices]
[Pages 29106-29107]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-14432]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Center for Human Genome Research; Notice of Closed
Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix), notice is hereby given of the following
meetings of the National Center for Human Genome Research Special
Emphasis Panel:
Agenda/Purpose: To review and evaluate grant applications and/or
contract proposals.
Name of Committee: National Center for Human Genome Research
Special Emphasis Panel 01.
Date: June 24, 1996.
Time: 7:00 p.m.
Place: NIH, Natcher (Building 45), Rooms G1/G2, 9000 Rockville
Pike, Bethesda, Maryland
Contact Person: Ms. Linda Engel, Chief, Office of Scientific
Review, National Center for Human Genome Research, National
Institutes of Health, Building 38A, Room 604, Bethesda, Maryland
20892, (301) 402-0838.
Name of Committee: National Center for Human Genome Research
Special Emphasis Panel 02.
Date: June 25, 1996.
Time: 9:00 a.m.
Place: NIH, Natcher (Building 45), Rooms G1/G2, 9000 Rockville
Pike, Bethesda, Maryland.
Contact Person: Ms. Linda Engel, Chief, Office of Scientific
Review, National Center for Human Genome Research, National
Institutes of Health, Building 38A, Room 604, Bethesda, Maryland
20892, (301) 402-0838.
Name of Committee: National Center for Human Genome Research
Special Emphasis Panel 03.
Date: June 25, 1996.
Time: 9:00 a.m.
Place: NIH, Natcher (Building 45), Rooms F1/F2, 9000 Rockville
Pike, Bethesda, Maryland.
Contact Person: Ms. Linda Engel, Chief, Office of Scientific
Review, National Center for Human Genome Research, National
Institutes of Health, Building 38A, Room 604, Bethesda, Maryland
20892, (301) 402-0838.
The meetings will be closed in accordance with the provisions
set forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. The
applications and/or contract proposals, and the discussions could
reveal confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
[[Page 29107]]
This notice is being published less than fifteen days prior to the
meetings due to the urgent need to meet timing limitations imposed by
the grant review cycle.
(Catalog of Federal Domestic Assistance Program No. 93.172, Human
Genome Research.)
Dated: June 4, 1996.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 96-14432 Filed 6-6-96; 8:45 am]
BILLING CODE 4140-01-M
